"Designing Growth Strategies is in our DNA"

Cell Viability Assays Market Size, Share, and COVID-19 Impact Analysis, By Product (Equipment and Reagents & Kits), By Application (Stem Cell Research, Diagnosis, and Drug Discovery & Development), By End-Users (Hospitals & Clinics, Clinical Laboratories, Academic & Research Centers, and Others), and Region Forecast, 2024-2032

Region :Global | Report ID: FBI107769 | Status : Ongoing

 

KEY MARKET INSIGHTS

A cell viability assay is carried out to assess cells' physical and physiological status when subjected to extracellular stimuli, treatments, and some chemical agents. These assays are applicable for determining optimal growth conditions in a particular cell culture.


Measurement of cell viability is essential for developing new drug therapies for chronic diseases such as cancer. The key factor driving the market expansion for cell viability assays is the rising number of people with chronic conditions.


  • For instance, according to data published by WHO in February 2022, nearly 10 million people died due to cancer in 2020, making it the leading cause of death globally. The most common cancers are breast, prostate, lung, colon, and rectum cancer.


Furthermore, government and non-government entities are heavily investing in developing therapeutics for cancer, which is expected to fuel the growth in the market.


  • For instance, in February 2022, according to data published by National Cancer Institute, President Biden announced a re-ignition of the cancer moonshot. He highlighted new goals: to reduce the death rate caused by cancer within 25 years and improve cancer patients' quality of life.


Impact of COVID-19 on the Cell Viability Assays Market


The cell viability assay market faced a slightly positive impact in 2020 due to the initiation of drug discovery and treatment programs related to cell viability assay. Cellular-based therapies have considerably increased the usage of the cell viability assay during the COVID-19 pandemic to comprehend the viability and response of living cells to COVID-19 infection.

For instance, in August 2020, Calidi Biotherapeutics announced FDA Approval for the IND (investigational new drug) application submitted for COVID-19 treatment. This application was submitted by its partner, Personalized Stem Cells (PSC), a biopharmaceutical company. Calidi Biotherapeutics has partnered with PSC for two years to contribute to stem cell therapy manufacturing for COVID-19 patients.

Stem cell therapy has received the greatest attention as a new treatment method, and research method for COVID-19, and stem cells are playing an important role in fighting against COVID-19. More cell viability assays were performed due to the growing need for stem cell therapy; hence the market is anticipated to expand in the coming years. Additionally, increasing R&D will allow market players to introduce new products anticipated to accelerate market expansion.


  • For instance, in January 2022, according to data published in Springer, stem cell therapy is available only for patients who have recovered from severe COVID-19 complications to repair damaged lungs, making it an ideal treatment.


Key Insights


The following key insights will be covered in the report:


  • Prevalence of Key Chronic Diseases - by Key Countries/Regions, 2022.

  • New Product Launches, Key Players.

  • Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.).

  • Impact of COVID-19 on the Cell Viability Assays Market.


Analysis by Products


Based on the product, the instruments segment accounted for a considerable proportion of the cell viability assay market in 2022. The growth was mainly attributed to the constant innovation and the development of new staining methods for delivering appropriate results.  


  • For instance, in November 2022, as per the article published by Springer Nature Limited, imaging flow cytometry combines the high-event-rate nature of flow cytometry with the advantages of single-cell image acquisition associated with microscopy. 

  • In November 2021, as per the article published by Select Science, flow cytometry enhanced the accuracy and limits the non-specific staining by using new tools.

  • In March 2019, according to data published on B.D., the new automated flow cytometry sample preparation instrument was launched by B.D. having CE-IVD certification


Regional Analysis


To gain extensive insights into the market, Request for Customization


North America dominated the cell viability assay market in 2022 and is projected to maintain its position over the forecast period. The majority of the growth in the U. S. is due to the rising cancer burden and steadily growing geriatric population. The key reasons fueling the market growth are the rising prevalence of cancer, an established medical infrastructure, and advanced diagnostic testing. The increasing population burden due to cancer is a key factor driving the market growth.


  • For instance, according to data published by the American Cancer Society, Inc., cancer is Canada's primary cause of death. Prostate cancer in males and breast cancer in females are the most commonly diagnosed type of cancer, while lung cancer remains the most common cause of cancer death in both sexes. It was estimated that around 1.9 million new cancer cases and 693,000 cancer deaths occurred in Northern America in 2018.  


Key Players Covered


The profile of key players will be included in the reports, such as Thermo Fisher Scientific Inc., Abcam plc., PerkinElmer Inc., Merck KGaA, Bio-Rad Laboratories Inc., Promega Corporation., Agilent Technologies, Inc., Creative Bioarray, and others.

Segmentation


















By Product


By Application


By End-Users


By Geography



  • Equipment

  • Reagents & Kits  




  • Stem Cell Research

  • Diagnosis

  • Drug Discovery & Development




  • Hospitals & Clinics

  • Clinical Laboratories

  • Academic & Research Centers

  • Others




  • North America (U.S. and Canada)

  • Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the Rest of Europe)

  • Asia Pacific (Japan, China, Australia, India, Southeast Asia, and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, and Rest of Latin America

  • Middle East & Africa (GCC, South Africa, and Rest of the Middle East and Africa)



Key Industry Developments



  • September 2022: Nanolive launched the live cell death assay. The company developed a ground-breaking tool that provides an automated solution for profiling cell health, death, apoptosis, and necrosis.

  • October 2021: Curi Bio and NEXEL announced Celogics, a joint venture company, to develop leading iPSC-derived cell products. This partnership focused on developing and commercializing human iPSC-derived cell products for drug safety testing, drug discovery, and biological research.

  • April 2021: Halo Labs launched the "Aura CL" for cell therapy. The product developed by the company can distinguish therapeutic cells from contaminants and other particles that might adversely harm patients. This product has been completely effective for cell therapy and product quality analysis. This product launch strengthens the company's scientific instrument product portfolio cell.





  • Ongoing
  • 2023
  • 2019-2022
  • Pre Book
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Healthcare Clients
Galemed
uniliver
Roche
iqvia
Styker
Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X